2002
DOI: 10.1073/pnas.252648999
|View full text |Cite
|
Sign up to set email alerts
|

Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2

Abstract: Ventricular septal defects are common in human infants, but the genetic programs that control ventricular septation are poorly understood. Here we report that mice with a targeted disruption of the cardiovascular basic helix-loop-helix factor (CHF)1͞Hey2 gene show isolated ventricular septal defects. These defects result primarily in failure to thrive. Mice often succumbed within the first 3 wk after birth and showed pulmonary and liver congestion. The penetrance of this phenotype varied, depending on genetic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
144
1

Year Published

2003
2003
2015
2015

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 169 publications
(148 citation statements)
references
References 48 publications
3
144
1
Order By: Relevance
“…However, it is unclear whether Tbx5 can directly regulate the expression of these genes in the developing heart in vivo. The microarray data listed in Table 1 includes two Tbx5-induced genes, hey2, and odd-skipped related 1, that are also associated with septal defects (Donovan et al, 2002;Gessler et al, 2002;Sakata et al, 2002;Wang et al, 2005). Loss of either gene in mice results in atrial or ventricular septal defects similar to those found in tbx5ϩ/Ϫ mice (Donovan et al, 2002;Gessler et al, 2002;Sakata et al, 2002;Wang et al, 2005).…”
Section: Discussionmentioning
confidence: 97%
“…However, it is unclear whether Tbx5 can directly regulate the expression of these genes in the developing heart in vivo. The microarray data listed in Table 1 includes two Tbx5-induced genes, hey2, and odd-skipped related 1, that are also associated with septal defects (Donovan et al, 2002;Gessler et al, 2002;Sakata et al, 2002;Wang et al, 2005). Loss of either gene in mice results in atrial or ventricular septal defects similar to those found in tbx5ϩ/Ϫ mice (Donovan et al, 2002;Gessler et al, 2002;Sakata et al, 2002;Wang et al, 2005).…”
Section: Discussionmentioning
confidence: 97%
“…Inhibition of HEY1 activity by RNAi approaches or by pharmacological inhibition of Notch receptor signals prevents major features of TGF-b-directed EMT such as disassembly of E-cadherin adherens junctions, disassembly of cortical actin and cell motility (Zavadil et al, 2004). The significance of H/Espl as direct targets of TGF-b signaling pathway in the context of EMT is further underscored by Tgfb2 and Hey2 gene ablation experiments in mice, revealing overlapping defects in cardiogenesis, suggesting that these proteins may be components of a functional pathway directing EMT in endothelial cushion remodeling during cardiac development (Camenisch et al, 2002;Donovan et al, 2002;Sakata et al, 2002). While TGF-b-induced expression of H/Espl repressors is reminiscent of the rapid recruitment of other transcriptional regulators (Slug, Snail, dEF or Twist) in order to silence epithelial-specific genes such as E-cadherin and contribute to the overall pattern of TGF-b-induced gene repression, the targets of H/Espl function in the specific context of EMT in development as well as disease pathogenesis remain to be identified.…”
Section: Id E2a Twistmentioning
confidence: 99%
“…Like HES, HRT proteins function as transcriptional repressors and have been identified as effectors of the Notch signaling pathway. They have been shown to be involved in cardiovascular development (Chin et al, 2000;Zhong et al, 2000;Henderson et al, 2001;Gessler et al, 2002;Sakata et al, 2002) and are also likely to play a crucial role in somitogenesis (Leimeister et al, 2000), myogenesis (Sun et al, 2001), and gliogenesis (Satow et al, 2001).…”
Section: Introductionmentioning
confidence: 99%